Trial Profile

A phase I study for Methylmalonic acidemia (MMA)

Status: Planning

Phase of Trial: Phase I

Latest Information Update: 28 Sep 2020

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs AAV based gene therapies Asklepios BioPharmaceutical/Selecta Biosciences (Primary)
Indications Methylmalonic acidaemia
Focus Adverse reactions
Sponsors Selecta Biosciences

Most Recent Events

28 Sep 2020 New trial record
06 Aug 2020 According to a Selecta Biosciences media release, this trial is conducted in collaboration with AskBio, is expected to enter the clinic in the first half of 2021, with preliminary data expected in 2H 2021.

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com